Healthcare
Nektar Therapeutics
NKTRPrice is delayed.
About Nektar Therapeutics
Nektar Therapeutics is a drug development company that focuses on immunotherapy, which means treatments that work by helping or regulating a person's immune system. The company is testing several experimental medicines in clinical trials to treat autoimmune diseases like multiple sclerosis and ulcerative colitis, as well as certain cancers. Nektar partners with major pharmaceutical companies like Pfizer, AstraZeneca, and Bristol-Myers Squibb to develop and commercialize these drugs. The company was founded in 1990 and is based in San Francisco.
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore